Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale President & CEO sold 6,571 shares at $5.87 ($38,564)
  2. 4 Open-market sale EVP & Chief Business Officer sold 1,645 shares at an average $6.30 ($10,368)
  3. 4 Open-market sale EVP & Chief Financial Officer sold 1,908 shares at an average $6.31 ($12,035)
  4. 4 Open-market buy Director bought 2,647,058 shares at $6.80 ($17,999,994)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award EVP & Chief Business Officer acquired 9,375 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
  10. 4 Grant or award EVP & Chief Scientific Officer acquired 4,688 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award EVP & Chief Financial Officer acquired 9,375 shares (grant or award)
  14. 4 Open-market buy Director bought 2,453,988 shares at $3.84 ($9,423,314)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 11 · 206 filings